UBS O'Connor’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-7,987
| Closed | -$344K | – | 565 |
|
|
2024
Q1 | $344K | Sell |
7,987
-6,689
| -46% | -$288K | 0.01% | 351 |
|
|
2023
Q4 | $676K | Sell |
14,676
-34,000
| -70% | -$1.57M | 0.02% | 310 |
|
|
2023
Q3 | $1.66M | Buy |
48,676
+10,000
| +26% | +$342K | 0.03% | 265 |
|
|
2023
Q2 | $1.49M | Sell |
38,676
-24,715
| -39% | -$952K | 0.03% | 336 |
|
|
2023
Q1 | $2.27M | Buy |
+63,391
| New | +$2.27M | 0.05% | 293 |
|
|
2022
Q4 | – | Sell |
-54,208
| Closed | -$1.96M | – | 332 |
|
|
2022
Q3 | $1.96M | Sell |
54,208
-42,000
| -44% | -$1.52M | 0.02% | 623 |
|
|
2022
Q2 | $2.93M | Buy |
+96,208
| New | +$2.93M | 0.03% | 469 |
|